CVR number 42591270
Industry 47.7400 Retail sale of medical and orthopaedic goods in specialised stores

Hørbart ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  3.6% 3.6% 3.6% 3.6% 3.6%  
Bankruptcy risk  0.0% 0.0% 0.0% 17.1% 9.3%  
Credit score (0-100)  0 0 0 9 25  
Credit rating  N/A N/A N/A BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 391 1,502  
EBITDA  0.0 0.0 0.0 -315 362  
EBIT  0.0 0.0 0.0 -335 321  
Pre-tax profit (PTP)  0.0 0.0 0.0 -351.5 288.3  
Net earnings  0.0 0.0 0.0 -276.2 222.1  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -351 288  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Tangible assets total  0.0 0.0 0.0 133 166  
Shareholders equity total  0.0 0.0 0.0 -236 -14.1  
Interest-bearing liabilities  0.0 0.0 0.0 291 285  
Balance sheet total (assets)  0.0 0.0 0.0 765 1,121  
Net Debt  0.0 0.0 0.0 291 285  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 391 1,502  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 284.2%  
Employees  0 0 0 0 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 765 1,121  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 46.5%  
Added value  0.0 0.0 0.0 -334.9 361.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 114 -8  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% -85.7% 21.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -33.4% 30.1%  
ROI %  0.0% 0.0% 0.0% -115.1% 111.6%  
ROE %  0.0% 0.0% 0.0% -36.1% 23.6%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% -23.6% -1.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -92.2% 78.7%  
Gearing %  0.0% 0.0% 0.0% -123.1% -2,026.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 11.6% 11.4%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.3 0.5  
Current Ratio  0.0 0.0 0.0 0.5 0.7  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -492.1 -316.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 121  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 121  
EBIT / employee  0 0 0 0 107  
Net earnings / employee  0 0 0 0 74